Mass. General Hospital has joined a World Heart Corp.’s (NSDQ:WHRT) heart pump study.
The Boston-based hospital will take part in the circulatory support system maker’s bridge-to-transplant clinical study of its Levacor ventricular assist device.
MGH, Louisville, Ky.-based University of Louisville/Jewish Hospital and Tampa, Fla.-based Tampa General Hospital joined three other hospitals in the study.